Shih–Jer Hsu

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Mei‐Jyh Chen et al. · The Lancet · 2012 · 269 citations

Medicine, Internal Medicine, Pharmacology +7

Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial

Chen‐Hua Liu, Chun‐Jen Liu, Chih‐Lin Lin et al. · Clinical Infectious Diseases · 2008 · 184 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chung‐Yu Chang et al. · Journal of Antimicrobial Chemotherapy · 2012 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

Ching‐Sheng Hsu, Shih–Jer Hsu, Hung-Chia Chen et al. · Proceedings of the National Academy of Sciences · 2011 · 63 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B

Shang‐Chin Huang, Tung‐Hung Su, Tai‐Chung Tseng et al. · Hepatology International · 2023 · 58 citations

Medicine, Biochemistry, Internal Medicine +17